BBIO vs BR · rev $221.9M vs P/E 16, rev $6.89B
BridgeBio Pharma Inc (BBIO) versus Broadridge Financial Solutions Inc (BR) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported BR revenue for 2025-06-30 was $6.89B. Net income was $839.5M. Revenue was up 5.9% from 2024-06-30 to 2025-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
BBIO currently screens at market cap $13.24B. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Not investment advice. Open the BBIO and BR stock pages for the full models.
Not investment advice.